Shares of the student lender, which had shot up 70% on news of the infusion one day earlier, pulled back 26% to $3.79 after investors reconsidered their positions. The capital infusion of around $132 million was about $70 million short of what Goldman Sachs had promised First Marblehead last December, but still showed some confidence in the student lender.
First Marblehead shares have nosedived following the bankruptcy of TERI, which had at one time guaranteed the soundness of the loans that the company provides.
FinancialWire" is a fully independent, proprietary news wire service of Investrend Information (a division of Investrend Communications, Inc.). FinancialWire" news is written by professional journalists, dedicated to pure journalistic standards. FinancialWire" does not receive or accept any compensation from any individual or subject company (or representative thereof) for its news or opinions. All FinancialWire" news is available at http://www.financialwire.net . Please address any inquiries to feedback@financialwire.net .
Free annual reports for companies mentioned in the news are available at http://investrend.ar.wilink.com/?level=279 .
http://www.financialwire.net

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index